Hospital News and Research

RSS

New England's program to keep students out of tanning beds

What do Kelli Pedroia, Lesley Green all have in common? They are all passionate advocates for the Melanoma Foundation of New England's program to keep students out of tanning beds.

1 Mar 2011

Routine blood test can reduce hospital readmissions in patients with heart failure

An inexpensive, routine blood test could hold the key to why some patients with congestive heart failure do well after being discharged from the hospital and why others risk relapse, costly readmission or death within a year, new Johns Hopkins research suggests.

1 Mar 2011

Tenofovir gel more effective than oral tablet for HIV treatment: Study

In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal tissue than did the oral tablet, while, compared to the gel, the tablet used daily was associated with a 20-times higher active drug concentration in blood.

1 Mar 2011

New cell therapy can reverse effect of 'bad' LDL cholesterol and reduce atherosclerosis

Researchers at the Swedish medical university Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of 'bad' LDL cholesterol and reduce the inflammation that leads to atherosclerosis.

1 Mar 2011

Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the highest proportion of surveyed cardiologists identify furosemide as the most efficacious agent for the treatment of acute heart failure when compared to other available therapies.

1 Mar 2011

Intercell reports EUR 255.2m net loss for full year 2010

Today Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company's development programs.

1 Mar 2011

Scientists to launch international working group to tackle HIV

More than 30 scientists gathered for a one-day meeting prior to the 18th Conference on Retroviruses and Opportunistic Infections to launch an international working group on HIV reservoirs and strategies to control them.

1 Mar 2011

Uterine fibroid treatments greatly improve quality of life in women

Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to a new study published in the May issue of Radiology.

1 Mar 2011

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30- or 60-minute application. The new treatment patch uses capsaicin - the substance found in chilli peppers which gives them their 'heat' - to change the function of pain sensing nerves in the area of skin affected.

1 Mar 2011

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.

1 Mar 2011

HCI creates Pediatric Cancer Late Effects Clinic to help manage long-term issues of treatment

Although cancer in children is rare, more than 10,000 children in the United States are diagnosed with some form of the disease every year. If these children survive, studies have found that more than two-thirds develop at least one late-effect of treatment, which can include additional cancers, fertility and heart problems, limited limb function, and hearing loss.

1 Mar 2011

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Sangamo BioSciences, Inc. announced today the presentation of positive preliminary clinical data from its Phase 1 trial.

1 Mar 2011

Brain's reward/motivation circuits linked to compulsive overeating

A brain imaging study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory reveals a subtle difference between ordinary obese subjects and those who compulsively overeat, or binge: In binge eaters but not ordinary obese subjects, the mere sight or smell of favorite foods triggers a spike in dopamine - a brain chemical linked to reward and motivation.

1 Mar 2011

Researchers combine old bones and new technology to treat chronic back pain

The bones of people who died up to a hundred years ago are being used in the development of new treatments for chronic back pain. It is the first time old bones have been used in this way.

1 Mar 2011

Despite absence of Medicare coverage, hospital use of CTC is on the rise: Study

Despite the absence of Medicare coverage, hospital use of computed tomographic colonography, commonly referred to as virtual colonoscopy, is on the rise, according to a study in the March issue of the Journal of the American College of Radiology.

1 Mar 2011

New process automatically ensures optimum tension for sutures in minimally invasive surgeries

More and more often, abdominal surgeries are being carried out in a minimally invasive manner. A small incision in the abdominal wall is sufficient for the surgeon to be able to insert the instrument and make the organs visible with an endoscope. This technique is gentler and does not stress the body as much as traditional surgeries do.

1 Mar 2011

Researcher identifies substance that inhibits cancer growth by activating 'dark genome'

A research study coordinated by Manel Esteller, researcher at Bellvitge Biomedical Research Institute (IDIBELL) has identified a substance that inhibits cancer growth by activating the so‑called "dark genome" (or non‑coding DNA) and micro‑RNA molecules. The study appears this week in the journal Proceedings of the National Academy of Sciences (PNAS).

1 Mar 2011

New study: Lifestyle intervention can help pregnant women control their weight

Excessive weight gain isn't healthy at any stage of life, but during pregnancy it can do lasting harm to the mother and baby alike. Now researchers at Brown University and The Miriam Hospital are encouraged by a new study describing an intervention that helped pregnant women control their weight.

1 Mar 2011

Nile plans to develop novel therapeutics for ADHF

Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, announced plans to pursue a new indication in the field of heart failure.

1 Mar 2011

New nasal vaccine holds promise against both Alzheimer's disease and stroke

One in eight Americans will fall prey to Alzheimer's disease at some point in their life, current statistics say. Because Alzheimer's is associated with vascular damage in the brain, many of them will succumb through a painful and potentially fatal stroke.

1 Mar 2011

Hospital News and Research

New England's program to keep students out of tanning beds

Routine blood test can reduce hospital readmissions in patients with heart failure

Tenofovir gel more effective than oral tablet for HIV treatment: Study

New cell therapy can reverse effect of 'bad' LDL cholesterol and reduce atherosclerosis

Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy

Intercell reports EUR 255.2m net loss for full year 2010

Scientists to launch international working group to tackle HIV

Uterine fibroid treatments greatly improve quality of life in women

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

HCI creates Pediatric Cancer Late Effects Clinic to help manage long-term issues of treatment

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Brain's reward/motivation circuits linked to compulsive overeating

Researchers combine old bones and new technology to treat chronic back pain

Despite absence of Medicare coverage, hospital use of CTC is on the rise: Study

New process automatically ensures optimum tension for sutures in minimally invasive surgeries

Researcher identifies substance that inhibits cancer growth by activating 'dark genome'

New study: Lifestyle intervention can help pregnant women control their weight

Nile plans to develop novel therapeutics for ADHF

New nasal vaccine holds promise against both Alzheimer's disease and stroke

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News